These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6694915)

  • 1. Acid phosphatase-producing androgen-independent subline of rat prostatic adenocarcinoma (Dunning R3327 tumor) in cell culture.
    Igarashi T; Isaka S; Miyauchi T; Hayata I; Shimazaki J
    Prostate; 1984; 5(1):113-22. PubMed ID: 6694915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM; Culp DA
    Trans Am Assoc Genitourin Surg; 1977; 69():72-7. PubMed ID: 617916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
    Presnell SC; Borchert KM; Glover WJ; Gregory CW; Mohler JL; Smith GJ
    Carcinogenesis; 1998 Apr; 19(4):585-90. PubMed ID: 9600341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of two sublines derived from rat prostatic adenocarcinoma (Dunning R 3327 tumor).
    Minagawa H; Miyauchi T; Wakisaka M; Fuse H; Matsuzaki O; Shimazaki J
    Gan; 1983 Aug; 74(4):524-33. PubMed ID: 6195040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olfactory bulbectomy, melatonin, and/or pinealectomy on three sublines of the Dunning R3327 rat prostatic adenocarcinoma.
    Toma JG; Amerongen HM; Hennes SC; O'Brien MG; McBlain WA; Buzzell GR
    J Pineal Res; 1987; 4(3):321-38. PubMed ID: 3625464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.
    Lubaroff DM; Canfield L; Feldbush TL; Bonney WW
    J Natl Cancer Inst; 1977 Jun; 58(6):1677-89. PubMed ID: 864747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines.
    Johnson MP; Thompson SA; Lubaroff DM
    J Urol; 1985 Jun; 133(6):1112-20. PubMed ID: 4039764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.
    Garde SV; Sheth AR; Porter AT; Pienta KJ
    Cancer Lett; 1993 Jul; 70(3):159-66. PubMed ID: 7689036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an in vitro clonogenic assay for the R3327 rat prostatic adenocarcinoma permits comparison of the proliferative potential of the R3327, R3327A, and R3327AT tumors.
    Dibner JJ; Nakeff A
    Prostate; 1983; 4(3):289-306. PubMed ID: 6844160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dunning adenocarcinoma in tissue culture: isolation of a cloned cell line, R3327H-G8-A1.
    Sestili MA; Norris JS; Lipschultz LI; Smith RG
    J Urol; 1982 Apr; 127(4):823-5. PubMed ID: 7040704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of new human prostatic cancer cell line (JCA-1).
    Muraki J; Addonizio JC; Choudhury MS; Fischer J; Eshghi M; Davidian MM; Shapiro LR; Wilmot PL; Nagamatsu GR; Chiao JW
    Urology; 1990 Jul; 36(1):79-84. PubMed ID: 2195744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A; Block NL; Stover BJ; Irvin GL
    Cancer Res; 1985 Mar; 45(3):1052-7. PubMed ID: 3971360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma.
    Tjota A; Lee MT; Isaacs JT; Kadohama N; Lee CL
    J Urol; 1991 Jul; 146(1):205-12. PubMed ID: 2056591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice.
    Hoehn W; Wagner M; Riemann JF; Hermanek P; Williams E; Walther R; Schrueffer R
    Prostate; 1984; 5(4):445-52. PubMed ID: 6739375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.
    Nelson WG; Cho KR; Hsiang YH; Liu LF; Coffey DS
    Cancer Res; 1987 Jun; 47(12):3246-50. PubMed ID: 3034406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
    Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
    Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
    Lee C; Murphy GP; Chu TM
    Cancer Res; 1980 Apr; 40(4):1245-8. PubMed ID: 7357554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.